# Albemarle Corporation – Consensus ‘buy’ rating and 62.0% Upside Potential

- Link: https://www.directorstalkinterviews.com/albemarle-corporation-consensus-buy-rating-and-62.0-upside-potential/4121133006
- Published: 2023-11-16T12:31:59+00:00
- Author: Charlotte Edwards

**Albemarle Corporation** which can be found using ticker (ALB) now have 25 confirmed
analysts covering the stock with the consensus suggesting a rating of ‘buy’. The
target price High/Low ranges between $327.43 and $90.00 and has a mean target at
$202.96. Now with the previous closing price of $125.32 this is indicating there
is a potential upside of 62.0%. Also worth taking note is the 50 day moving average
now sits at $153.14 and the 200 day moving average is $201.13. The market capitalization
for the company is 14.99B. The stock price is currently at: $127.72 USD

 The potential market cap would be $24,274,101,615 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 4.53, revenue per share of $84.27
and a 8.56% return on assets.

Albemarle Corporation is a global developer, manufacturer and marketer of specialty
chemicals. The Company operates through three segments: Energy Storage, Specialties
and Ketjen. The Energy Storage business contributes to the growth of clean miles
driven with electric vehicles and more efficient use of renewable energy through
grid storage. Its Specialties segment enables the prevention of fires starting in
electronic equipment, greater fuel efficiency from rubber tires and the reduction
of emissions from coal-fired power plants. The Ketjen business creates efficiency
of natural resources through more usable products from a single barrel of oil, enables
safer, greener production of alkylates used to produce more environmentally friendly
fuels, and reduced emissions through cleaner transportation fuels. It serves the
markets, such as serve include energy storage, petroleum refining, consumer electronics,
construction, automotive, lubricants, pharmaceuticals and crop protection.

Share on: